Corval provides a clear path from the clinic to the market, freeing innovative biopharma leaders to focus on getting treatments to the patients they serve.
Founder & CEO
Letter from Our Founder
It has often been said, life experience shapes who you are and where you focus your passions. Growing up in a large family with many siblings and different points of view, I learned early the value of navigating the inevitable day-to-day chaos to get to a place of resolution to keep moving forward!
I have applied this learning in my career, helping biopharma leaders understand that “commercialization is a mindset,” represented by an organization-wide effort to bring their innovative medicines to market.
After decades of work with hundreds of clients, I’ve witnessed the fragmented commercialization planning process and how it bogs down early- to mid-stage companies that have yet to build their internal capabilities.
As an entrepreneur, I knew there has to be a better way.
- There was a way to create a roadmap that is completely aligned with your company, product, and strategy?
- It was possible to create a budget and workforce plan from your own unique roadmap?
- This platform was designed with you in mind and was affordable for your company size and budget?
- You could utilize this platform on your own, or across your company, as a single source of truth?
At Corval, we have turned these “what ifs” into a cloud-based commercialization platform that will guide your strategic planning and lead you from the clinic to the market—freeing you up to think bigger and drive innovation for the patients you are committed to serving.
We’re a team with big ideas committed to changing the way that innovative therapies get to patients. And we’re growing every day.
Susan is a proven leader and successful entrepreneur in the life science industry. In addition to founding and leading Corval, a novel SaaS platform company, she is the CEO and Founder of The NemetzGroup, a successful, strategic commercialization consultancy. The NemetzGroup has been instrumental in supporting the evolution of over 100 biopharma companies from startup to publicly traded and the development of numerous assets from targets to approved, life-saving treatments. With more than 35 years of corporate strategy, commercial, medical affairs, business development, and operational experience, C-suite leadership teams rely on her thought partnership and mentoring to achieve goals across all stages of drug development.
Prior to launching The NemetzGroup in 2003, Susan served as Vice President, Global Commercial Strategy, and then Vice President of International Commercial Operations at Millennium Pharmaceuticals. Previously, she progressed through multiple commercial leadership roles at DuPont Pharmaceuticals that culminated in her appointment as Executive Vice President of the cardiovascular and imaging franchise. Susan serves as an advisor of Life Science Cares, a collective effort of the life science industry to eliminate the impact of poverty on Boston neighborhoods. Susan received her BS in business management from the University of Minnesota.
Jason serves as the Chief Operating Officer at Corval. Jason has worked in leadership and client-facing roles in healthcare technology and life sciences for the last 10+ years, at both established global firms and start-ups. From diverse experiences, he has gained a holistic view of the US healthcare ecosystem through the lens of providers, payers, distributors, and life sciences manufacturers. Most recently, Jason led strategy engagements at IQVIA for top life sciences companies, helping client teams to solve key challenges in pharmaceutical commercialization and market access in the US and global markets.
Jason also brings extensive experience managing growth-stage start-ups. He was employee #1 and Chief Operating Officer at MDCalc, a SaaS platform providing prescribers with evidence-based clinical decision support. Along with building a diverse team across all functional areas and initiating several revenue models, Jason oversaw product, content, sales/marketing and expansion of a technology platform—including mobile apps and EHR integrations—used by >2 million healthcare providers globally. Jason has also advised founders on strategy and operations for a pre-commercial pharma business, a med-tech company, and a DTC health platform. Jason has an MBA from Columbia Business School and a BA in International Business from Loyola University New Orleans.
Sales & Business
Dan joined Corval as Executive Director of Sales and Business Development in 2022. He has over 30 years of biopharma sales and commercialization experience and brings a unique blend of commercialization, analytics, sales, and client service expertise. Most recently, Dan was Executive Director of Business Development at EVERSANA, where he was responsible for forging comprehensive commercial services partnerships with emerging pharma and biotech clients. Prior to that, he held senior business development and client service roles at Parexel, IQVIA, Health Strategies Group, and Publicis. Dan’s professional services experience and sales leadership roles at Astra Zeneca and Oscient will enable him to achieve Corval business goals while building external strategic relationships and internal commercial capabilities. Dan lives in the greater Los Angeles area has a BA in Economics from Long Beach State University. He is passionate about making a difference for clients as they grow and develop.
Mairelisa serves as Corval’s Product Development Intern, where she coordinates across product and content workflows to support data management, quality analysis, and ongoing product upgrades. Prior to joining Corval, Mairelisa worked for the US Census Bureau, the Mayor's Office of Workforce Development, and the Grand Circle Corporation, where she held a range of responsibilities and gained technical skills in database management, project management, and product and software development. Currently pursuing a BA in Economics at UMass Amherst, Mairelisa enthusiastically continues to support the Corval vision.
Melinda joins Corval as Marketing Lead, where she is responsible for the strategy, development, and execution of marketing, brand, and messaging efforts. She has a proven track record of success in building top-flight systems from the ground-up for start-ups and medium- to enterprise-level organizations specializing in biotech and life sciences. Most recently, Melinda led marketing communications at Cold Chain Technologies, where she executed the successful pivot to provide specialized packaging solutions in response to the COVID-19 pandemic and the CDC’s Operation Warp Speed. Preceding that, she led digital marketing and social media efforts for a variety of life science and consumer product companies. Melinda has a BFA in Graphic Design from the University of Connecticut, School of Fine Arts.
Casey joins Corval as a Business Analyst, where she is responsible for data analytics and insight mining to help drive product development efforts. Prior to joining Corval, Casey was a Corps Support Intern at City Year Boston, where she managed events and seminars for incoming members and external partners. Casey also served as a Public Affairs Intern at Planned Parenthood of Northern New England, where she assisted in a research study in collaboration with Duke University to determine the effectiveness of deep-canvassing initiatives. Casey is a recent graduate from Hamilton College, where she earned a BA in Government and Hispanic Studies. She is also a proud alum of NOLS, where she bravely led a team expedition through the Yukon, CA wilderness.
Radhika Sabnis joined Corval in 2022 as a Customer Coordinator where she is responsible for overseeing all project activities related to onboarding customers. She has several years of project management experience in the biopharma and healthcare domain and has led complex workstreams spanning software implementation, manufacturing, operations, and quality and process improvement. In her recent position with Healthcentric Advisors, she worked with hospital systems and clinicians throughout Massachusetts to maintain healthcare quality compliance, streamline workflows, and maximize Medicare payments. She has held similar management and consulting roles at Partners HealthCare, Exeter Health Resources, and Lonza Biologics. In addition to her PMP certification, Radhika holds an MS in Genetic Engineering from Bangalore University and an MBA from the University of New Hampshire.
Lindsay serves as the Manager Business Operations, where she is responsible for coordinating cross-functional activities and operational logistics.
She has over 15 years of experience in executive administration and event coordination, supporting teams to streamline workflows and ensure business goals are achieved. Most recently, Lindsay was the Conference Center Manager at Berkshire Partners, where she oversaw execution of more than 800 investor events annually. Preceding that, she was a Marketing Assistant at Jefferies Financial Group, where she supported timely execution of sales and marketing campaigns. Lindsay earned her BA in communications from Keene State College.
We couldn't do it without the help of our product and development partners.
We are a small and mighty team building a product at the exciting intersection of biopharma and technology.
We value our customers, our partners, and our people. We believe in a culture of learning, collaboration, empathy, and diversity. We believe that work and life should be in balance and that striving for excellence can co-exist with striving for happiness. If you are interested in helping us build this innovative company, learning a lot, and having fun while doing it, we’d love to hear from you.
Email us at email@example.com.
Follow us on LinkedIn.
Corval is aligned with the Life Science Cares mission to make a meaningful impact on poverty by harnessing the resources of the life sciences industry. As a sign of our commitment, we are donating a portion of sales to Life Science Cares.